ArticleFrontiers in immunology2026
Phosphoproteomics uncovers a neuroimmune perspective on trigeminal neuralgia: sexually dimorphic regulatory networks linking calcium channels to the complement cascade.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trigeminal neuralgia (TN) is a neuropathic pain disorder with a marked female predominance. While transcriptional changes in TN are documented, the translational and post-translational landscapes-specifically protein abundance and phosphorylation states-within the trigeminal ganglion (TG) remain largely unexplored. Understanding these layers is essential to deciphering the mechanisms behind the disease's sexual dimorphism. Methods: we utilized the chronic infraorbital nerve ligation (CION) method via an intraoral approach model in male and female Sprague-Dawley rats. Mechanical allodynia was confirmed via behavioral testing. On postoperative day 7, trigeminal ganglia were harvested to capture the somatic molecular response. We performed an integrated analysis using TMT-based quantitative proteomics and phosphoproteomics. Bioinformatics tools were employed to map differentially expressed proteins (DEPs), kinase-substrate relationships, and protein-protein interaction (PPI) networks. Results: The study quantified 5,820 proteins and 8,830 phosphopeptides. (1) A striking divergence was observed in pathological pathways. Females exhibited a robust neuroimmune signature characterized by the specific upregulation of complement components (C1QA, C1QC) and Kininogen (KNG1). In contrast, males showed alterations primarily in lipid metabolism and synaptic vesicle cycles. (2) Phosphoproteomics identified the MAPK signaling pathway as a shared mechanism. Specifically, phosphorylation of HSPB1 at Ser86 (pS86-HSPB1)-a target of the MAPKAPK2/3 cascade-was significantly elevated, linking stress signaling to cytoskeletal reorganization. (3) PPI analysis highlighted voltage-gated calcium channel subunits as central hubs connecting these sex-specific modules, validating the relevance of calcium channel modulation in TN management. Conclusions: This study presents the first dual-omics atlas of the injured trigeminal ganglion. We identify a female-specific "Complement-Kininogen" axis and a conserved "MAPK-HSPB1" phosphorylation pathway as key drivers of TN. These findings provide a molecular explanation for the clinical gender bias and suggest that therapeutic strategies may need to be sex-stratified, with complement inhibition holding particular potential for female patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.